Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Detection Technology Plc - Managers' Transactions

Detection Technology Plc Managers' Transactions 5 June 2017 at 10:30 (EEST) Detection Technology Plc - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Hyvärinen, Kari Position: Other senior manager Issuer: Detection Technology Plc LEI: 743700IXKYKNXJ6BFL39 Notification type: INITIAL NOTIFICATION Reference number: 743700IXKYKNXJ6BFL39_20170605085705_2 ____________________________________________ Transaction date: 2017-06-02 Venue: FIRST NORTH FINLAND (FNFI) Instrument type: SHARE

Ahlstrom-Munksjö announces indicative Tender Offer results

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES (AS DEFINED BELOW), THE TENDER OFFER (AS DEFINED BELOW) OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. AHLSTROM-MUNKSJÖ STOCK EXCHANGE RELEASE, JUNE 5, 2017 at 8:50 CEST Ahlstrom-Munksjö Oyj (the “Company”) announces today the indicative results of the invitation to the holders of

OV- The efficacy of chemotherapy with epirubicin, one the of most used drugs in Breast Cancer can now be predicted by DRP – Poster published at ASCO

Hoersholm, Denmark, June 5th, 2017 – Oncology Venture Sweden AB (“Oncology Venture”) today announced that the previously published abstract with DRP data for epirubicin for breast cancer was presented as a poster on the poster session ‘Breast Cancer—Metastatic’ Board 63; Abstract 1071 on the 4th of June 2017 at 8:00 AM-11:30 AM local time/15:00-18:30 CET. The title is “Retrospective-prospective blinded evaluation predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort”.  The DRP was significantly associated

Sea Shepherd Germany announces Baltic Sea Campaign with new patrol ship

With a new patrol ship donated by Dr. Bronner’s, Sea Shepherd’s new campaign aims to protect critically endangered harbor porpoises in the Baltic Sea.FOR IMMEDIATE RELEASE June 5, 2017 The Baltic Sea harbor porpoise is listed by the IUCN (International Union for Conservation of Nature) as “critically endangered”, with a population estimated to be less than 500 individuals in 2016. The harbor porpoise is protected under EU law, and therefore member states are obliged to take measures to ensure the protection of their natural habitats. However, because of exemptions to these

Episurf Medical AB will be exhibiting at the Irish Orthopaedic Association's Annual Meeting, held in Kilkenny, Ireland, on June 16-18

Episurf Medical AB will participate at Irish Orthopaedic Association's Annual Meeting, an orthopaedic conference held in Kilkenny, Ireland, (Lyrath Hotel) on June 16-18. For full program, see link. . For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).  For more information, please contact: Pål Ryfors, CEO, Episurf Medical  Tel: +46 (0) 709 62 36 69 Email: pal.ryfors@episurf.com About Episurf Medical Episurf Medical is endeavoring to bring people with painful joint

Chinmax Medical Systems Inc. to distribute Acetium® Lozenge in China

Biohit Oyj press release 5 June 2017 at 9:30 am. local time (EEST) Biohit Oyj and Chinmax Medical Systems Inc. have signed an agreement for the distribution of the Acetium lozenge in China. The agreement has been signed for a preliminary period of seven years and includes an option and a letter of intent for a joint venture arrangement and local production if the sales targets set out in the agreement are met. The Acetium lozenge can be used to bind carcinogenic acetaldehyde in saliva to a harmless compound during smoking and to promote oral health. Acetium lozenge has been found to

Diamyd Medical subscribes for an additional SEK 1 million in NextCell Pharma’s ongoing new issue ahead of IPO

Diamyd Medical announces today that the Company will subscribe for an additional SEK 1 million in the ongoing new issue in the associated company NextCell Pharma AB (NCP) ahead of their planned IPO in July on Aktietorget."A listing of NextCell Pharma is clearly positive for Diamyd Medical as it provides a transparent value of our holdings and better risk diversification, while giving NCP greater opportunities to drive its research and business development," says Ulf Hannelius, CEO of Diamyd Medical. NextCell Pharma develops advanced cell therapies with own and donated stem cells. The

Notice of the Extraordinary General Meeting 2017

The shareholders of Avanza Bank Holding AB (publ.) are hereby given notice of the Extraordinary General Meeting of the company to be held on Wednesday, 5 July 2017 at 10.00 (CET) at Konferens Spårvagnshallarna, Birger Jarlsgatan 57 A, in Stockholm.Entitlement to attend the General Meeting Shareholders wishing to attend the General Meeting shall, firstly, be entered in the register of shareholders maintained by Euroclear Sweden AB no later than Thursday, 29 June 2017, and secondly, notify of their intention to participate in the General Meeting by email to bolag@avanza.se or by telephone

Directorate Changes

5 June 2017 Genel Energy plc Directorate Changes Genel Energy plc (‘Genel’ or ‘the Company’) announces that Nathaniel Rothschild and Simon Lockett have resigned from the Board. Accordingly, they will no longer stand for re-election at the Annual General Meeting of Genel Energy on 6 June 2017. Simon Lockett was Chairman of the HSSE Committee and member of the Audit and Nomination Committees. Board Committee memberships are under review and updates will be made when appropriate. Tony Hayward, Chairman of Genel, said: "Nat contributed greatly to Genel’s development as both a

Information about insider transaction at SaltX Technology

The Executive Vice President and CTO of SaltX Technology, Göran Bolin has per June 2, 2017, sold 159 000 B-shares (including BTA) and 135 064 warrants TO2 of his holding in SaltX Technology Holding AB. The sale, which has been registered at Finansinspektionen, was done due to personal financial reasons. After the sale, Göran Bolin holds a total of 133 200 B-shares (including BTA) in the Company, as well as 166 000 warrants TO2 and 100 000 TO3.For further information, please contact: Harald Bauer, CFO SaltX Technology, phone +46 (0)708 10 80 34

Finnair’s Pekka Vauramo to be oneworld Governing Board Chairman

Pekka Vauramo, Chief Executive of Finnair, has been nominated by the Governing Board of the oneworld® global airline alliance to serve as its Chairman for the two years ahead. He took up the role at oneworld’s mid-year Board meeting, held today in Cancun, where airline industry leaders from around the world are gathering for the IATA annual meeting which opens tomorrow. He succeeds Ivan Chu, who has moved on from his role as Chief Executive of Cathay Pacific Airways to become Chairman of John Swire & Sons (China) Limited, after leading the alliance for two years. His successor as

Nordic Waterproofing provides an update of the competition case

On 31 May 2017, as communicated by Nordic Waterproofing by an announcement on the same day, the Danish Competition and Consumer Authority (the “DCCA”) issued a decision (“the Decision”) to providers of waterproofing products in Denmark, including Nordic Waterproofing A/S, a Danish subsidiary of Nordic Waterproofing Holding A/S (STO:NWG.ST). The Decision relates to the application of the standard setting organization TOR’s product standards for waterproofing products and orders TOR to repeal its product standards and Nordic Waterproofing to seize its participation in TOR.Also as previously

WINDPASSENGER: FLY WITHOUT WINGS MARKET LEADERS IN PORTUGAL SINCE 2004

PORTUGAL: AN INCREASINGLY MORE ATTRACTIVE DESTINATIONPortugal has been establishing itself as a major international tourist destination.   Every year it succeeds as the best tourist destination, with the best beaches, best short-breaks...   From Lisbon to Oporto, from Alentejo to Algarve to the amazing North and country's interior, Portugal has a rich historical, cultural and natural heritage capable of satisfying the most demanding tastes.   But if you already know all of Portugal charms, seen from the ground, discover the country from another perspective.  Climb aboard a hot air

Pirjo Pakkanen is resigning the Board of Directors of Tecnotree Corporation

Tecnotree CorporationStock Exchange Release3 June 2017 at 13:30 pm EET   Pirjo Pakkanen is resigning the Board of Directors of Tecnotree CorporationPirjo Pakkanen, the Board Member of Tecnotree Corporation is resigning the Board of Directors of the company. The resignation is effective immediately. Thereafter, the Board has four members.TECNOTREE CORPORATIONThe Board of DirectorsMORE INFORMATIONHarri Koponen, Chairman of the Board, tel. +358 40 1922 464 About TecnotreeTecnotree is a global provider of IT solutions for the management of services, products, customers

Nevada Becomes 23rd State to Modernize Insurance Laws Allowing E-Card, E-Delivery and E-Posting

CARSON CITY, Nev. — With the recent signature of AB 455 by Gov. Brian Sandoval, Nevada becomes the 23rd state to modernize insurance laws to keep pace with how consumers want to receive their insurance policy documents and information, says the Property Casualty Insurers Association of America (PCI).  Assembly Bill 455 gives consumers the choice to receive their insurance policies, documents and consumer notices electronically. This legislation also enables insurers to post standard policy forms and endorsements online in lieu of mailing paper documents. “Increasingly consumers want to

NRC Group ASA - Acquisitions of own shares

Oslo, 2 June 2017. Reference is made to the announcement made by NRC Group ASA (the "Company"') on 11 May 2017 in connection with its decision to initiate a share buyback program for up to NOK 10 million in the market. The Company has today bought 50.000 shares in the Company through broker at an average price of NOK 56.2263 per share.The Company's total holding of treasury shares after this transaction is 268.165 shares.For further information, please contact:CFO Dag Fladby, telephone: +47 90 89 19 35.This information is subject to the disclosure requirements pursuant to section

Kamux Oyj: Stabilization measures taken

Kamux Corporation   Stock Exchange Release   2 June 2017 at 20:00 Not for publication, distribution or release, in whole or in part, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand, South Africa, Singapore, or any other jurisdiction where it would be against the law. Stabilization measures taken With reference to the offering circular published by Kamux Corporation ("Kamux", "Company") on 2 May 2017 and company announcement dated on 11 May 2017 regarding the result of the initial public offering of Kamux (the "Offering"), Kamux

Regarding proposals to Vigmed's annual general meeting 2017

The nomination committee of Vigmed Holding AB has notified the company that, in view of Vigmed's new ownership structure, the nomination committee will not submit any proposals to the annual general meeting 2017.  Vigmed's new majority shareholder, Greiner Bio-One GmbH ("GBO"), has notified Vigmed that GBO will submit proposals to the annual general meeting 2017 as soon as possible. Vigmed will announce the proposals as soon as they have been received by the company.For further information contact:Chairman of the Board Sten Dahlborg, +46 708-369 419This is a translation of the

BioStock publishes analysis of Idogen

Today, June 2 2017, BioStock has published an analysis of Idogen. The analysis is now available on BioStock’s, Idogen’s and Redeye’s respective websites (www.biostock.se ,  www.idogen.com , http://beta.redeye.se/transaction/idogen). On behalf of Idogen, Biostock has analyzed the company’s project portfolio and will continue to follow the company for one year.Extract from BioStock’s analysis: “BioStock has analyzed deal values

#17-517 Listing of instrument issued by SG Issuer

As from June 05, 2017, 1 instrument issued by SG Issuer will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB. Issuer: SG Issuer Agent: Exceed For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.se Nordic Growth Market NGM ABAbout NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se), a

#17-516 Listing of instrument issued by SG Issuer

As from June 05, 2017, 1 instrument issued by SG Issuer will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB. Issuer: SG Issuer Agent: Exceed For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.se Nordic Growth Market NGM ABAbout NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se), a

Exercise of warrants in the Byggmax Group AB (publ)

Under the framework of the incentive program established in May 2013 (TO2 2013/2017), for which the subscription period for shares (May 30, 2017 until November 30, 2017) has now opened, employees of the Byggmax Group have subscribed for shares in the Byggmax Group AB (publ) (the “Company”).In May 2013, the Company adopted an incentive program comprising an assignment of warrants to key individuals in the Byggmax Group. Furthermore, the warrants were issued free of any consideration to the wholly owned subsidiary Byggmax AB to later, in turn, be assigned to the participants in the incentive

#17-515 Listing of instrument issued by SG Issuer

As from June 05, 2017, 1 instrument issued by SG Issuer will be listed on NDX Structured Products Sweden. The instrument will be registered at Euroclear Sweden AB. Issuer: SG Issuer Agent: Exceed For more details see attached file. For further information concerning this NDX notice please contact: NDX Listing on +46 8 566 390 20 or at ndxlist@ngm.se Nordic Growth Market NGM ABAbout NDX Nordic derivatives Exchange (NDX) is a market for listing and trading of derivatives and other structured products. The market is operated by Nordic Growth Market (www.ngm.se), a

Ossur Hf : Insider trading

Announcement Össur hf. No.43/2017 Reykjavík, 2 June 2017   Auðkenni útgefanda/Trade ticker: OSSR                                                                                                                                                                      Nafn útgefanda/Issuer: Össur hf. Dagsetning tilkynningar/Date of announcement: 2 June 2017 Nafn fruminnherja/Name primary insider: William Demant Invest A/S Tengsl fruminnherja við útgefanda/Insider's relation with the issuer: Niels Jacobsen Dagsetning viðskipta/Date of transaction: 2 June

There are no items matching the current filter
There are no more items matching the current filter
Back to top